Topic
Every article tagged “Depression”, newest first.
248 articles · page 3 of 7 · Mar 10, 2026 – Apr 15, 2026
Archive summary Clinical
Compass Pathways (NASDAQ:CMPS) executives outlined the company’s latest Phase 3 depression data and commercialization preparations during a Needham conference session…
Archive summary Clinical
Nanobiotix (NASDAQ:NBTX – Get Free Report) and NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) are both small-cap medical companies, but which is the better stock?…
Archive summary Clinical
Archive summary Clinical
NRx Pharmaceuticals (NASDAQ: NRXP), a biopharmaceutical company focused on neuroplastic therapies for depression, PTSD and related conditions, announced the appointment…
Archive summary Clinical
NRx Pharmaceuticals (Nasdaq: NRXP) has announced the appointment of Glenn Tyson as the company's first Chief Commercial Officer as it anticipates approval of an…
Archive summary Clinical
NRx Pharmaceuticals (NASDAQ: NRXP) said Founder, Chairman and CEO Jonathan Javitt, M.D., M.P.H., will present at NobleCon21 on Dec. 3 at 4:30 p.m. EST, offering an ...
Archive summary Clinical
66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohorts ...
Archive summary Clinical
HOUSTON, April 8, 2026 /PRNewswire/ -- We Level Up Treatment Centers, a national leader in dual-diagnosis addiction and mental health treatment, is announcing the growth…
Archive summary Clinical
66.7% of participants achieved an antidepressant response by Day 2 following a single intranasal dose of BPL-003 in both the 10 mg (n=6) and 12 mg (n=6) cohorts Durable…
Archive summary Clinical
Archive summary Clinical
Archive summary Clinical
Archive summary Clinical
NRx Pharmaceuticals (NASDAQ: NRXP) announced it has received a letter from the FDA Office of Generic Drugs indicating only minor formatting comments on the ...
Archive summary Clinical
NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx's preservative-free ketamine product. ...
Archive summary Clinical
NRx Pharmaceuticals announced that it received preliminary FDA alignment on labeling for its preservative-free ketamine product. The Labeling Program of the FDA Office…
Archive summary Clinical
AUSTIN, TX / ACCESS Newswire / April 2, 2026 / Unfortunately, chronic back pain has silenced too many lives for too long. It has stolen sleep, canceled plans, ended…
Archive summary Clinical
In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically significant reduction from baseline in HAM-D17 total score compared…
Archive summary Clinical
WALTHAM, Mass.--(BUSINESS WIRE) $CYCN--Cyclerion Therapeutics, Inc. (“Cyclerion”) (Nasdaq: CYCN) and Korsana Biosciences, Inc. (“Korsana”), a privately-held…
Archive summary Clinical
$11.6M Department of Defense-supported multi-side study evaluates rapid, personalized, drug-free neuromodulation therapy at leading research centers
Archive summary Clinical
Major Depressive Disorder affects many patients seeking behavioral healthcare treatment. According to AltaPointe Health, a system serving 45,000 patients, research…
Archive summary Clinical
A 44-year-old man who spent 31 years living with severe, treatment-resistant depression alongside PTSD and panic disorder experienced significant improvement through an…
Archive summary Clinical
(MedPage Today) -- An individualized dosing regimen of the inhaled psychedelic mebufotenin (GH001) led to significant improvements in depression symptoms in patients…
Archive summary Clinical
LONDON & NEW YORK--(BUSINESS WIRE) $CMPS Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based…
Archive summary Clinical
EINPresswire/ -- Madorra Inc., a medical device company developing innovative solutions for menopause-related conditions, today announced the enrollment of the first…
Archive summary Clinical
NRx Pharmaceuticals (NASDAQ: NRXP) announced it received a letter from the FDA's Bioequivalence Program stating no bioequivalence deficiencies were identified at ...
Archive summary Clinical
Top 5 natural antidepressants ranked by science: St. John's Wort, SAM-e, omega-3s, saffron, rhodiola.
Archive summary Clinical
Determination of bioequivalence to the Reference Listed Drug is essential for approval of an Abbreviated New Drug Application (ANDA). FDA has advised NRx in ...
Archive summary Clinical
AtaiBeckley announced the peer-reviewed publication of results from its ongoing four-part Phase 2a study of BPL-003 in the Journal of Psychopharmacology.
Archive summary Clinical
LifeStance Health offers tips on how to maintain mental wellness and emotional balance while entering retirement
Archive summary Clinical
NRx Pharmaceuticals Inc. (NASDAQ:NRXP) shares are surging on Monday following positive developments regarding its New Drug Application for NRX-100 (preservative-free…
Archive summary Clinical
WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has…
Archive summary Clinical
NRx has received confirmatory FDA minutes from in-person Type C meeting attended by leadership of FDA Division of Psychiatry, FDA Office of Neuroscience, and FDA ...
Archive summary Clinical
NRx Pharmaceuticals (NASDAQ: NRXP) announced that minutes from a Type C meeting with the U.S. Food and Drug Administration support the agency's willingness to ...
Archive summary Clinical
Understanding what depression is – and what it is not – is often the first step toward relief.
Archive summary Clinical
Archive summary Clinical
Researchers have discovered a surprising change in how cells produce energy in people with depression. Brain and blood cells in young adults with major depressive…
Archive summary Clinical
The below clickable headlines link directly to outside media outlets, which featured UNC School of Medicine faculty starting Friday, March 6, 2026. Continue reading
Archive summary Clinical
When choosing the best berberine supplements, we've prioritised high bioavailability, trusted brands and formulations with minimal fillers
Archive summary Clinical
Exton, PA, March 10, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights today announced the release of its 2026 Patient Chart DynamixTM: Sickle Cell Disease (US) report,…
Archive summary Clinical
BPL‐003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depressionCash runway reaffirmed through the planned…